Obesity Clinical Trial
Official title:
Role of Dairy Products in Weight Maintenance: Prevention of Weight Regain Following Weight Loss
The goal of the current study is to determine the role of dairy in similarly preventing weight and fat re-gain in obese adults who have successfully completed a weight loss diet program.240 obese subjects will undergo a meal-replacement-based weight loss plan designed to produce a 10 kg weight loss in 8-12 weeks. Upon achieving the weight loss goal, subjects will be randomly assigned to either a low-dairy or high-dairy eucaloric weight maintenance diet for two years. Macronutrient distribution will be maintained constant and set at approximately the U.S. average. Primary outcomes include changes in body weight, body fat and anatomical distribution of fat (via dual x-ray absorptiometry) and resting metabolic rate and substrate oxidation (via respiratory calorimetry); Secondary outcomes include blood pressure, circulating glucose, insulin, lipids and calcitrophic hormones. on prevention of weight regain in humans has not yet been assessed in clinical trials.
Dietary calcium plays a pivotal role in the regulation of energy metabolism, as we have
found high calcium diets to attenuate adipocyte lipid accretion and weight gain during
periods of over-consumption of an energy-dense diet and to increase lipolysis and preserve
thermogenesis during caloric restriction, thereby markedly accelerating weight loss. Our
studies of the agouti gene demonstrate a key role for intracellular Ca2+ in regulating
adipocyte lipid metabolism and triglyceride storage, with increased intracellular Ca2+
resulting in stimulation of lipogenic gene expression and lipogenesis and suppression of
lipolysis, resulting in adipocyte lipid filling and increased adiposity. Moreover, the
increased calcitriol produced in response to low calcium diets stimulates adipocyte Ca2+
influx and, consequently, promotes adiposity, while higher calcium diets inhibit
lipogenesis, promote lipolysis, lipid oxidation and thermogenesis and inhibit diet-induced
obesity in mice. Notably, dairy sources of calcium exert markedly greater effects in
attenuating weight and fat gain and accelerating fat loss. This augmented effect of dairy
products versus supplemental calcium is likely due to additional bioactive compounds in
dairy which act synergistically with calcium to attenuate adiposity. These concepts are
confirmed by both epidemiological and clinical data which demonstrates that increasing
dietary calcium results in significant reductions in adipose tissue mass in obese humans in
the absence of caloric restriction and markedly accelerates the weight and body fat loss
secondary to caloric restriction, while dairy products exert markedly greater (nearly
two-fold compared to calcium supplements) effects. These data indicate an important role for
dairy products in both the prevention and treatment of obesity. However, weight maintenance
following successful weight loss (i.e. prevention of regain) is at least as important as
strategies to initially achieve weight loss, as most individuals who successfully lose
weight are not successful in maintaining this weight loss. We have recently demonstrated
that ad libitum re-feeding of dairy-rich following weight loss in mice on an energy
restricted mice prevented the suppression of adipose tissue lipolysis and fat oxidation that
otherwise accompanies such re-feeding and markedly upregulated skeletal muscle fat
oxidation. Consequently, although animals re-fed low calcium diets rapidly regained all of
the weight and fat that had been lost, animals fed high calcium diets exhibited a shift in
energy partitioning and a 50-85% reduction in weight and fat gain; moreover, dairy exerted
markedly greater effects than supplemental calcium on weight and fat regain. However, the
effect of dairy on prevention of weight regain in humans has not yet been assessed in
clinical trials. Accordingly, the goal of the current study is to determine the role of
dairy in similarly preventing weight and fat re-gain in obese adults who have successfully
completed a weight loss diet program.
340 obese subjects will undergo a meal-replacement-based weight loss plan designed to
produce a 10 kg weight loss in 8-12 weeks. Upon achieving the weight loss goal, subjects
will be randomly assigned to either a low-dairy or high-dairy eucaloric weight maintenance
diet for two years. Macronutrient distribution will be maintained constant and set at
approximately the U.S. average. Primary outcomes include changes in body weight, body fat
and anatomical distribution of fat (via dual x-ray absorptiometry) and resting metabolic
rate and substrate oxidation (via respiratory calorimetry); Secondary outcomes include blood
pressure, circulating glucose, insulin, lipids and calcitrophic hormones.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |